Pacer Advisors Inc. Sells 370,923 Shares of Bath & Body Works, Inc. $BBWI

Pacer Advisors Inc. cut its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 18.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,666,156 shares of the company’s stock after selling 370,923 shares during the quarter. Pacer Advisors Inc.’s holdings in Bath & Body Works were worth $31,107,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of BBWI. Parallel Advisors LLC raised its position in Bath & Body Works by 35.5% in the 1st quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after buying an additional 673 shares during the last quarter. Caerus Investment Advisors LLC bought a new position in Bath & Body Works during the 1st quarter valued at $208,000. Segall Bryant & Hamill LLC boosted its holdings in Bath & Body Works by 17.7% during the 1st quarter. Segall Bryant & Hamill LLC now owns 327,089 shares of the company’s stock worth $6,107,000 after acquiring an additional 49,100 shares during the last quarter. Bank of America Corp DE boosted its holdings in Bath & Body Works by 26.2% during the 1st quarter. Bank of America Corp DE now owns 2,050,414 shares of the company’s stock worth $38,281,000 after acquiring an additional 425,248 shares during the last quarter. Finally, South Dakota Investment Council grew its stake in shares of Bath & Body Works by 4.2% in the 1st quarter. South Dakota Investment Council now owns 1,756,048 shares of the company’s stock worth $32,785,000 after acquiring an additional 71,255 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $21.00 on Tuesday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.32. The company has a market capitalization of $4.23 billion, a PE ratio of 5.90, a price-to-earnings-growth ratio of 1.99 and a beta of 1.38. The business has a fifty day moving average price of $20.21 and a two-hundred day moving average price of $20.34.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, June 19th. Shareholders of record on Friday, June 5th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s payout ratio is presently 22.47%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Morgan Stanley reiterated an “equal weight” rating and issued a $22.00 target price on shares of Bath & Body Works in a report on Monday, July 6th. The Goldman Sachs Group downgraded shares of Bath & Body Works from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $23.00 to $19.00 in a research report on Wednesday, July 8th. Jefferies Financial Group upped their price objective on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Telsey Advisory Group decreased their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research note on Thursday, May 28th. Finally, Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $21.93.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.